Governance ICON Public Limited Company

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
186.58 ^USD	-1.76%		+0.38%	-11.03%

Dec. 09	ICON plc Releases Findings from Two Biotech Sector Survey	CI
Dec. 02	Icon survey reveals increasing clinical trial startup delays	RE

Executive Committee: ICON Public Limited Company

Manager

Positions heldSince

Nigel Bernard John Clerkin

52 year

Director of Finance/CFO

2024-09-30

Kate Haven

Investor Relations Contact

Joe Cronin

Human Resources Officer

2013-12-31

Tom O'Leary

Chief Tech/Sci/R&D Officer

Diarmaid Cunningham

50 year

Chief Administrative Officer	2016-06-30
General Counsel	2009-10-31
Corporate Secretary	-

Simon Holmes

Chief Investment Officer

Composition of the Board of Directors: ICON Public Limited Company

Director

CommitteesSince

Ciaran Murray

62 year

Chairman	2017-02-28
Independent Dir/Board Member	2018-04-30

Linda Grais

67 year

Audit Committee	2019-01-27
Governance Committee	2021-06-30
Nominating Committee	2021-06-30
Compensation Committee	2021-06-30
Organization Committee	2021-06-30

Julie O'Neill

59 year

Compensation Committee Chair	2024-08-29
Audit Committee	2021-05-02
Audit Committee Chair	2022-08-31
Compensation Committee	2019-07-22
Organization Committee	2019-07-22

Rónán Murphy

67 year

Executive Committee	2016-10-17
Compensation Committee	2016-10-17
Organization Committee	2016-10-17
Audit Committee Chair	2019-02-18

Eugene McCague

66 year

Audit Committee	2017-10-03
Governance Committee Chair	2017-10-03
Nominating Committee Chair	2017-10-03

Anne Michelle Whitaker

57 year

Governance Committee	2024-07-22
Nominating Committee	2024-07-22

Stephen Cutler

64 year

Executive Committee

2015-11-24

John Climax

72 year

Director/Board Member	2009-12-31
Independent Dir/Board Member	2009-12-31

Latest Appointments: ICON Public Limited Company

Sep. 04	ICON plc Announces CEO Changes, Effective October 1, 2025	CI
Sep. 04	ICON plc Appoints Barry Balfe to the Board	CI
Sep. 04	Icon Promotes COO Barry Balfe to CEO Role	MT
Sep. 02	IQVIA names Michael Fedock as financial chief	RE
Apr. 03	Telix Pharmaceuticals Limited Announces Appointment of Anne Whitaker as A Non-Executive Director Based in the United States, Effective 7 April 2025	CI
Dec. 18	ICON Names Barry Balfe Chief Operating Officer	MT
Dec. 18	ICON plc Announces Appointment of Barry Balfe as Chief Operating Officer	CI

More news

Former Officers and Directors: ICON Public Limited Company

Insider

Positions held

SinceUntil

Paul McCracken

Corporate Officer/Principal

2016-10-13

2024-11-01

Brendan Brennan

Director of Finance/CFO	2012-01-31	2024-09-30
Investor Relations Contact	-	2024-09-30
Corporate Officer/Principal	2011-01-31	2012-01-31

Joan Garahy

Director/Board Member	2017-11-19	2024-07-22
Independent Dir/Board Member	2017-11-19	2024-07-22

Tami Klerr-Naivar

Corporate Officer/Principal

2023-12-01

Colin Shannon

Director/Board Member

2009-12-31

2022-12-30

Nuala Murphy

Corporate Officer/Principal

2012-08-25

2022-08-31

Hugh Brady

Director/Board Member	2014-04-29	2022-07-25
Independent Dir/Board Member	2014-04-29	2022-07-25

Mary K. Pendergast

Director/Board Member	2014-02-19	2022-07-25
Independent Dir/Board Member	2014-02-19	2022-07-25

William Walmsley Hall

Director/Board Member	2013-02-20	2022-07-25
Independent Dir/Board Member	2013-02-20	2022-07-25

Gregory Licholai

Chief Tech/Sci/R&D Officer

2021-10-31

Kristen Buck

Chief Tech/Sci/R&D Officer

2020-02-29

2021-06-30

Haichen Yang

Private Equity Investor

2016-02-29

2021-05-31

Neil McCullough

Compliance Officer	-	2020-09-30
Corporate Officer/Principal	-	2015-03-22

Anthony Japour

Chief Tech/Sci/R&D Officer

2016-01-31

2020-03-31

Dermot Kelleher

Director/Board Member	2008-04-30	2019-07-24
Independent Dir/Board Member	2008-04-30	2019-07-24

Declan McKeon

Director/Board Member	2010-03-31	2019-07-24
Chairman	2016-03-30	2017-02-28
Independent Dir/Board Member	2010-03-31	2018-12-31

Jin Jin Liang

Corporate Officer/Principal

2017-08-31

2019-06-30

Ronan Lambe

Director/Board Member	2007-12-31	2018-07-23
Chairman	1990-05-31	2002-10-31
Founder	1990-05-31	2018-07-23
Independent Dir/Board Member	1990-05-31	2018-07-23

Julie Ryan

Corporate Officer/Principal

2014-12-31

2017-12-31

Brendan Buckley

Chief Tech/Sci/R&D Officer

2013-07-11

2017-03-31

Dominic Smethurst

Corporate Officer/Principal

2015-06-30

2016-08-31

Thomas Gerard Lynch

Director/Board Member	2016-03-30	2016-07-21
Chairman	2013-01-27	2016-03-30
Independent Dir/Board Member	1994-07-31	2016-03-30

Sandra Mumanachit

Private Equity Analyst

2012-07-31

2014-09-30

Ira Spector

Corporate Officer/Principal

2014-09-09

Michael McGrath

Chief Tech/Sci/R&D Officer

2014-01-31

Cathrin Petty

Director/Board Member	2010-10-26	2014-01-23
Independent Dir/Board Member	2011-06-08	2014-01-23

Eric Humes

Corporate Officer/Principal

2008-12-31

2013-12-31

Kimberly Ma

Corporate Officer/Principal

2010-12-31

2013-12-31

Robert L. Howie

Sales & Marketing

2013-01-15

Bruce Given

Director/Board Member	2004-08-31	2010-01-06
Chairman	2010-01-06	2012-12-31
Independent Dir/Board Member	2004-08-31	2010-01-06

Peter Gray

Director/Board Member	2011-06-08	2012-07-18
Chief Executive Officer	2002-10-31	2011-08-31
Chief Operating Officer	2001-05-31	2002-10-31
Director of Finance/CFO	1997-05-31	2001-05-31

Alan Morgan

Chief Tech/Sci/R&D Officer	2011-06-15	-
Corporate Officer/Principal	2011-06-08	2011-06-15

Donald Kraft

Human Resources Officer	2011-12-31	2015-12-31
Corporate Officer/Principal	2015-12-31	-

George A. McMillan

Corporate Officer/Principal

2011-12-31

Anthony John Murphy

Director/Board Member	2009-04-26	2011-12-30
Independent Dir/Board Member	2011-06-08	2011-12-30

Nathalie Riebel

Chief Tech/Sci/R&D Officer

2001-11-30

2011-02-28

William P. Taaffe

Founder	-	2010-12-31
Corporate Officer/Principal	-	2010-12-31

Edward Roberts

Director/Board Member	1998-01-31	2010-04-18
Director/Board Member	-	-

Shuji Higuchi

Director/Board Member

2009-04-23

Richard Bryce

Chief Tech/Sci/R&D Officer

2007-07-31

2008-08-31

David Young

Corporate Officer/Principal

2003-08-31

Sian Bigora

General Counsel

2004-12-31

2005-12-31

Markus H. Weissbach

Corporate Officer/Principal

1995-12-31

2002-12-31

Elizabeth Thiele

Corporate Officer/Principal

2001-12-31

Eimear Kenny

Human Resources Officer

2009-09-23

Josephine Coyle

Corporate Officer/Principal

1992-07-31

Alice Lioi

Corporate Officer/Principal

Daniel White

Chief Operating Officer

Lee Jones

Director/Board Member

David Hinds

Corporate Officer/Principal

Stephen Toon

Corporate Officer/Principal

Jan Skoumal

Chief Tech/Sci/R&D Officer

Jonathan Curtain

Corporate Officer/Principal

Gillian Greer

Director/Board Member

John Hubbard

Corporate Officer/Principal

2009-12-31

Sam Farthing

Public Communications Contact

2011-04-06

Mark A. Quigley

Compliance Officer	2012-05-10	-
General Counsel	2011-06-08	2012-05-10

Kent Thoelke

Corporate Officer/Principal

Niamh Murphy

Public Communications Contact

Deirdre Murphy

Public Communications Contact

2009-09-23

Emily Brand

Public Communications Contact	-	-
Corporate Officer/Principal	2011-04-06	2011-06-15

Age distribution of managers

Parity Men Women

Male	14
Female	4

Of which Executive Committee

Male	5
Female	1

Of which Directors

Male	6
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Employees

39,800

Sector

Biotechnology & Medical Research

Calendar

Feb. 24 - Q4 2025 Earnings Release (Projected)

More about the company